subject: CHEBI:64153

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: Adult T-cell lymphoma/leukaemia recurrent

tested_intervention: unsure


subject: CHEBI:64153

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:64153

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:64153

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:64153

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:64153

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:64153

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:64153

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:64153

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:64153

object_name: splenic marginal zone lymphoma


subject: CHEBI:64153

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:64153

object_name: small intestine lymphoma


subject: CHEBI:93755

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:93755

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:93755

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:93755

object_name: MALT lymphoma


subject: CHEBI:93755

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:93755

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:93755

object_name: anaplastic large cell lymphoma


subject: CHEBI:93755

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:93755

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:93755

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:93755

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:93755

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:93755

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:93755

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:93755

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:93755

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:93755

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:93755

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:93755

object_name: splenic marginal zone lymphoma


subject: CHEBI:93755

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:93755

object_name: small intestine lymphoma


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: malnutrition

tested_intervention: yes


subject: CHEBI:73604

object_name: Critical Illness


subject: CHEBI:73604

object_name: Inflammation


subject: UMLS:C5854667


subject: UNII:N673F6W2VH

subject_name: Odanacatib

object_name: osteoporosis


subject: UNII:N673F6W2VH

object_name: Encounter due to family history of osteoporosis


subject: UNII:N673F6W2VH

object_name: Osteoporosis, CTCAE 5.0


subject: UNII:N673F6W2VH

object_name: Osteoporosis, CTCAE 3.0


subject: UNII:N673F6W2VH

object_name: postmenopausal osteoporosis


subject: PUBCHEM.COMPOUND:359323

subject_name: PENTAMIDINE ISETHIONATE

object_name: pneumocystosis


subject: PUBCHEM.COMPOUND:359323

object_name: HIV infection


subject: CHEBI:45081

subject_name: Pentamidine


subject: CHEBI:45081


subject: CHEBI:608828

subject_name: Enfuvirtide

object_name: AIDS


subject: CHEBI:608828


subject: UMLS:C0298960


subject: UMLS:C0298960


subject: CHEBI:17026

subject_name: Progesterone

object_name: Cannabis use


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: CHEBI:73604

object_name: Neuromuscular inhibition


subject: CHEBI:73604

object_name: Neuromuscular block, function


subject: CHEBI:73604

object_name: prostate carcinoma


subject: CHEBI:73604

object_name: prostate cancer


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Premature infant


subject: UMLS:C0445115

object_name: periventricular leukomalacia


subject: UMLS:C0445115

object_name: Periventricular Leukomalacia, AE


subject: UMLS:C0445115

object_name: Intracranial hemorrhage


subject: UMLS:C0445115

object_name: cerebral palsy


subject: CHEBI:114785

subject_name: Erlotinib

object_name: malignant peritoneal mesothelioma


subject: CHEBI:177406

subject_name: CDDO-Me


subject: PUBCHEM.COMPOUND:53315588


subject: UMLS:C3536985

subject_name: gimeracil + oteracil potassium + tegafur

object_name: colorectal cancer


subject: UMLS:C3536985

object_name: colorectal carcinoma


subject: UMLS:C3536985

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4547850

object_name: type 1 diabetes mellitus 1


subject: UMLS:C4547850

object_name: type 1 diabetes mellitus


subject: UNII:6DXN080KGB

subject_name: FRESPACIGUAT

object_name: pulmonary hypertension


subject: UNII:6DXN080KGB

object_name: Pulmonary Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:16034857

subject_name: Duotrav

object_name: ocular hypertension


subject: PUBCHEM.COMPOUND:16034857

object_name: Ocular hypertension


subject: PUBCHEM.COMPOUND:16034857

object_name: glaucoma


subject: PUBCHEM.COMPOUND:16034857

object_name: Glaucoma, CTCAE


subject: UMLS:C5854627

subject_name: Anti-SIRPa Monoclonal Antibody ADU-1805

object_name: Adult Solid Neoplasm


subject: UMLS:C5854627

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5854627

object_name: refractory malignant neoplasm


subject: CHEBI:16919

subject_name: Creatine

object_name: intermittent vascular claudication


subject: UNII:H15GT9J2LB

object_name: stroke disorder


subject: UNII:H15GT9J2LB

object_name: cerebrovascular disorder


subject: UNII:H15GT9J2LB

object_name: Stroke (heart beat)


subject: UNII:H15GT9J2LB

object_name: Stroke, CTCAE


subject: PUBCHEM.COMPOUND:131751561

subject_name: Cyclostenol

object_name: irritable bowel syndrome


subject: DRUGBANK:DB14276

subject_name: Turmeric


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: pneumonia childhood


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:8988

object_name: Carcinoma breast stage IV


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:188061

object_name: schizophrenia


subject: UMLS:C1569108

subject_name: URB 597


subject: UMLS:C0021027

subject_name: Immunoglobulins


subject: CHEBI:64073

object_name: Disorder of glucose regulation


subject: CHEBI:64073

object_name: Overweight and obesity


subject: CHEBI:64073

object_name: Androgen excess


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:9P1872D4OL


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Hepatitis C recurrent


subject: CHEBI:231951

object_name: type 2 diabetes mellitus


subject: PR:000029158

subject_name: immunoglobulin G-binding protein A

object_name: autoimmune thrombocytopenic purpura


subject: UMLS:C0038164

subject_name: Staphylococcal Protein A


subject: UMLS:C3659876

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C3659876

object_name: metabolic syndrome X


subject: CHEBI:125427

object_name: chronic kidney disease


subject: CHEBI:125427

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: UMLS:C3714610


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17823


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: UNII:1C6V77QF41


subject: UMLS:C2983764

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:118224658

object_name: Solid Neoplasm


subject: UNII:BL5NEF7JDK


subject: UMLS:C5959091

subject_name: Anti-PD-1/Anti-CD73 Bispecific Antibody AK131

object_name: triple-negative breast carcinoma


subject: UMLS:C5959091

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:16822

subject_name: choline sulfate


subject: CHEBI:16822


subject: CHEBI:15354

subject_name: Choline


subject: CHEBI:15354


subject: CHEBI:119486

subject_name: Efavirenz


subject: CHEBI:119486


subject: PUBCHEM.COMPOUND:156963498

subject_name: Mecapegfilgrastim


subject: PUBCHEM.COMPOUND:156963498


subject: UNII:I4QL0KKG3K

subject_name: pegylated granulocyte colony-stimulating factor


subject: UNII:I4QL0KKG3K


subject: CHEMBL.COMPOUND:CHEMBL5095279

subject_name: MECAPEGFILGRASTIM


subject: CHEMBL.COMPOUND:CHEMBL5095279


subject: UMLS:C3179328


subject: UMLS:C3179328


subject: CHEMBL.COMPOUND:CHEMBL4297828


subject: CHEMBL.COMPOUND:CHEMBL4297828


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C5418043

subject_name: ADC SHR-A1811


subject: UMLS:C5418043


subject: UMLS:C5854493

subject_name: Anti-nectin-4 Antibody-drug Conjugate SHR-A2102


subject: UMLS:C5854493


subject: CHEBI:59773

subject_name: CROMOLYN


subject: CHEBI:59773


subject: UNII:C137DTR5RG

subject_name: THEOPHYLLINE


subject: UNII:C137DTR5RG


subject: CHEBI:28177

subject_name: Theophylline


subject: CHEBI:28177


subject: CHEBI:93109

subject_name: Semaxanib

object_name: Plexosarcoma


subject: CHEBI:91083

subject_name: Romiplostim


subject: UNII:25E79B5CTM

subject_name: Denileukin diftitox

object_name: leukemia


subject: UNII:25E79B5CTM

object_name: childhood leukemia


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: CHEBI:230956


subject: CHEBI:45307

subject_name: Seliciclib


subject: CHEBI:16016

subject_name: Glycerone

object_name: concussion


subject: CHEBI:16016

object_name: Mild Traumatic Brain Injury


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: UMLS:C0251564

subject_name: Pulmozyme

object_name: Neck Carcinoma


subject: UMLS:C0251564

object_name: head and neck neoplasm


subject: UMLS:C0251564

object_name: head and neck cancer


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: pregnancy related


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: Prostate cancer recurrent


subject: UNII:4T36H88UA7

object_name: Adenocarcinoma of the prostate metastatic


subject: UNII:4T36H88UA7

object_name: Stage IVB Prostate Cancer AJCC v8


subject: CHEBI:6427

subject_name: Leuprolide


subject: CHEBI:6427


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: PUBCHEM.COMPOUND:21879648


subject: PUBCHEM.COMPOUND:21879648


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: rheumatoid arthritis


subject: CHEBI:23359

subject_name: colchicine


subject: CHEBI:23359

object_name: cardiovascular disorder


subject: CHEBI:4875

subject_name: Etanercept

object_name: psoriatic arthritis


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: CHEBI:139072

object_name: Compulsion


subject: CHEBI:8614

subject_name: Psilocybin


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Laryngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:2767

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:2767

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:2767

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:2767

object_name: Laryngeal squamous cell carcinoma stage III


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: PUBCHEM.COMPOUND:2767

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: PUBCHEM.COMPOUND:2767

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: PUBCHEM.COMPOUND:2767

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVA squamous cell carcinoma of the larynx


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVC squamous cell carcinoma of the larynx


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVB squamous cell carcinoma of the larynx


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: PUBCHEM.COMPOUND:2767

object_name: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:2767

object_name: Laryngeal verrucous carcinoma recurrent


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Laryngeal verrucous carcinoma stage III


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVC verrucous carcinoma of the larynx


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVB verrucous carcinoma of the larynx


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVA verrucous carcinoma of the larynx


subject: PUBCHEM.COMPOUND:2767

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: PUBCHEM.COMPOUND:2767

object_name: Verrucous carcinoma of the oral cavity stage III


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: tongue cancer


subject: PUBCHEM.COMPOUND:2767

object_name: tongue carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: mucositis


subject: UNII:R1UQ6D1ECM

subject_name: ENTOLIMOD

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UNII:R1UQ6D1ECM

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UNII:R1UQ6D1ECM

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UNII:R1UQ6D1ECM

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UNII:R1UQ6D1ECM

object_name: Laryngeal squamous cell carcinoma stage III


subject: UNII:R1UQ6D1ECM

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:R1UQ6D1ECM

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:R1UQ6D1ECM

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: UNII:R1UQ6D1ECM

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: UNII:R1UQ6D1ECM

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UNII:R1UQ6D1ECM

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: UNII:R1UQ6D1ECM

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UNII:R1UQ6D1ECM

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: UNII:R1UQ6D1ECM

object_name: stage IVA squamous cell carcinoma of the larynx


subject: UNII:R1UQ6D1ECM

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:R1UQ6D1ECM

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:R1UQ6D1ECM

object_name: stage IVC squamous cell carcinoma of the larynx


subject: UNII:R1UQ6D1ECM

object_name: stage IVB squamous cell carcinoma of the larynx


subject: UNII:R1UQ6D1ECM

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:R1UQ6D1ECM

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:R1UQ6D1ECM

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:R1UQ6D1ECM

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: UNII:R1UQ6D1ECM

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: UNII:R1UQ6D1ECM

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:R1UQ6D1ECM

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:R1UQ6D1ECM

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: UNII:R1UQ6D1ECM

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: UNII:R1UQ6D1ECM

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: UNII:R1UQ6D1ECM

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: UNII:R1UQ6D1ECM

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: UNII:R1UQ6D1ECM

object_name: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:R1UQ6D1ECM

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:R1UQ6D1ECM

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:R1UQ6D1ECM

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:R1UQ6D1ECM

object_name: Laryngeal verrucous carcinoma recurrent


subject: UNII:R1UQ6D1ECM

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: UNII:R1UQ6D1ECM

object_name: Laryngeal verrucous carcinoma stage III


subject: UNII:R1UQ6D1ECM

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: UNII:R1UQ6D1ECM

object_name: stage IVC verrucous carcinoma of the larynx


subject: UNII:R1UQ6D1ECM

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: UNII:R1UQ6D1ECM

object_name: stage IVB verrucous carcinoma of the larynx


subject: UNII:R1UQ6D1ECM

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: UNII:R1UQ6D1ECM

object_name: stage IVA verrucous carcinoma of the larynx


subject: UNII:R1UQ6D1ECM

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: UNII:R1UQ6D1ECM

object_name: Verrucous carcinoma of the oral cavity stage III


subject: UNII:R1UQ6D1ECM

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: UNII:R1UQ6D1ECM

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: UNII:R1UQ6D1ECM

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: UNII:R1UQ6D1ECM

object_name: tongue cancer


subject: UNII:R1UQ6D1ECM

object_name: tongue carcinoma


subject: UNII:R1UQ6D1ECM

object_name: mucositis


subject: UMLS:C2353146

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UMLS:C2353146

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C2353146

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UMLS:C2353146

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C2353146

object_name: Laryngeal squamous cell carcinoma stage III


subject: UMLS:C2353146

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C2353146

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2353146

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: UMLS:C2353146

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: UMLS:C2353146

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UMLS:C2353146

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: UMLS:C2353146

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UMLS:C2353146

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: UMLS:C2353146

object_name: stage IVA squamous cell carcinoma of the larynx


subject: UMLS:C2353146

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2353146

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2353146

object_name: stage IVC squamous cell carcinoma of the larynx


subject: UMLS:C2353146

object_name: stage IVB squamous cell carcinoma of the larynx


subject: UMLS:C2353146

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2353146

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C2353146

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2353146

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: UMLS:C2353146

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: UMLS:C2353146

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2353146

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2353146

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: UMLS:C2353146

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: UMLS:C2353146

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: UMLS:C2353146

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: UMLS:C2353146

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: UMLS:C2353146

object_name: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UMLS:C2353146

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UMLS:C2353146

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UMLS:C2353146

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UMLS:C2353146

object_name: Laryngeal verrucous carcinoma recurrent


subject: UMLS:C2353146

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: UMLS:C2353146

object_name: Laryngeal verrucous carcinoma stage III


subject: UMLS:C2353146

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: UMLS:C2353146

object_name: stage IVC verrucous carcinoma of the larynx


subject: UMLS:C2353146

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: UMLS:C2353146

object_name: stage IVB verrucous carcinoma of the larynx


subject: UMLS:C2353146

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: UMLS:C2353146

object_name: stage IVA verrucous carcinoma of the larynx


subject: UMLS:C2353146

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: UMLS:C2353146

object_name: Verrucous carcinoma of the oral cavity stage III


subject: UMLS:C2353146

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: UMLS:C2353146

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: UMLS:C2353146

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: UMLS:C2353146

object_name: tongue cancer


subject: UMLS:C2353146

object_name: tongue carcinoma


subject: UMLS:C2353146

object_name: mucositis


subject: UNII:23HYE36B0I

subject_name: Velaglucerase alfa

object_name: Gaucher disease


subject: UMLS:C2959261

subject_name: velaglucerase alfa 100 units injection


subject: UMLS:C2752138

subject_name: aloe vera homeopathic preparation

object_name: periodontitis


subject: DRUGBANK:DB13906

subject_name: Aloe vera leaf


subject: UMLS:C0995182

subject_name: Aloe vera preparation


subject: CHEBI:25805

subject_name: oxygen atom

object_name: coronary artery disorder


subject: CHEBI:25805

object_name: coronary atherosclerosis


subject: CHEBI:25805

object_name: no feeling or sensation of skin


subject: CHEBI:25805

object_name: Sensory Loss


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: CHEBI:15379


subject: CHEBI:15379


subject: UNII:YTM763Y5C8

subject_name: Anagrelide Hydrochloride Hydrate

object_name: essential thrombocythemia


subject: CHEBI:71940

subject_name: Tadalafil

object_name: Digital ulcer


subject: CHEBI:71940

object_name: Raynaud disease


subject: CHEBI:71940

object_name: scleroderma


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: Atopic rhinitis


subject: UNII:420K487FSG

object_name: Allergic Rhinitis, CTCAE


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: Tendon injury - hand


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: UMLS:C0065661

subject_name: rhMBL

object_name: Infection


subject: UMLS:C0065661

object_name: infectious disease


subject: UMLS:C0065661

object_name: Adverse Event Associated with Infection


subject: UMLS:C0065661

object_name: leukopenia


subject: UMLS:C0065661

object_name: neutropenia


subject: UMLS:C0065661

object_name: Fever, Sweat, and Hot Flashes


subject: UMLS:C0065661

object_name: unspecified childhood solid tumor, protocol specific


subject: UMLS:C0065661

object_name: Myelodysplasia


subject: UMLS:C0065661

object_name: leukemia


subject: UMLS:C0065661

object_name: childhood leukemia


subject: UMLS:C0065661

object_name: adult lymphoma


subject: UMLS:C0065661

object_name: lymphoma


subject: UMLS:C0065661

object_name: pediatric lymphoma


subject: GTOPDB:6934

subject_name: crenezumab

object_name: Alzheimer disease


subject: CHEMBL.COMPOUND:CHEMBL1743004

subject_name: CRENEZUMAB


subject: UMLS:C3493199


subject: UMLS:C0376159

subject_name: Arylsulfatase B

object_name: mucopolysaccharidosis type 6


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: psoriasis 14, pustular


subject: UNII:N5UK68MGDZ

object_name: pustulosis palmaris et plantaris


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: neuralgia


subject: CHEBI:168243

object_name: Phantom Limb Pain


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: Motor Neuron Disease, Upper


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Pruritus


subject: CHEBI:7459

subject_name: Naloxone


subject: UMLS:C5400018

subject_name: Defibrotide, Pig


subject: UNII:438HCF2X0M

subject_name: Defibrotide


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Consent Type - Hysterectomy


subject: CHEBI:64356

subject_name: Pregabalin


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Advanced cancer


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:9168

object_name: Embolism, Tumor


subject: CHEBI:9168

object_name: Neoplasm Metastasis


subject: MESH:D013607

subject_name: Tablets


subject: MESH:D013607


subject: MESH:D013607


subject: MESH:D013607


subject: UMLS:C0302908

subject_name: Liquid substance


subject: UMLS:C0302908


subject: UMLS:C0302908


subject: UMLS:C0302908


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Android obesity


subject: CHEBI:38545

object_name: Abdominal obesity


subject: CHEBI:50730

subject_name: Montelukast

object_name: Bronchospasm, Exercise-Induced


subject: CHEBI:2549

subject_name: Albuterol


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: liver carcinoma


subject: UNII:J5LT149M79

subject_name: marzeptacog alfa (activated)

object_name: hemophilia A


subject: UNII:J5LT149M79

object_name: hemophilia B


subject: UNII:J5LT149M79

object_name: hemophilia B leyden


subject: UNII:J5LT149M79

object_name: Hereditary factor VIII deficiency disease without inhibitor


subject: UNII:J5LT149M79

object_name: Hereditary factor IX deficiency disease without inhibitor


subject: UNII:J5LT149M79

object_name: Hereditary factor VIII deficiency disease with inhibitor


subject: UNII:J5LT149M79

object_name: Hereditary factor IX deficiency disease with inhibitor


subject: UMLS:C5139663


subject: UMLS:C5139663


subject: UMLS:C5139663


subject: UMLS:C5139663


subject: UMLS:C5139663


subject: UMLS:C5139663


subject: UMLS:C5139663


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: CHEBI:90841

subject_name: Cangrelor

object_name: ST-elevation myocardial infarction


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: CHEBI:49603

subject_name: Lapatinib


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: invasive tubular breast carcinoma


subject: CHEBI:45863

object_name: Mucinous breast cancer


subject: CHEBI:45863

object_name: breast mucinous carcinoma


subject: CHEBI:45863

object_name: invasive ductal breast carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: UNII:MW1GD0H4VS

subject_name: Besifovir dipivoxil maleate

object_name: hepatitis B


subject: CHEBI:71196

subject_name: glucagon-like peptide-1 receptor agonist

object_name: endometrial endometrioid adenocarcinoma


subject: UMLS:C2917359

subject_name: GLP-1 Receptor Agonist [EPC]


subject: PUBCHEM.COMPOUND:118613788

subject_name: COFROGLIPTIN

object_name: type 2 diabetes mellitus


subject: UNII:LH4G6K6NKP


subject: UMLS:C2348756

subject_name: Testosterone Gel

object_name: hypogonadism, male


subject: CHEBI:7772

subject_name: omeprazole

object_name: COPD, severe early onset


subject: CHEBI:7772

object_name: chronic obstructive pulmonary disease


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:32171

subject_name: Sulthiame

object_name: Epilepsy in children


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:8887

subject_name: Rofecoxib

object_name: Headache


subject: CHEBI:8887

object_name: Headache, CTCAE


subject: CHEBI:17087

subject_name: ketone

object_name: Hyperketonemia


subject: CHEBI:17087

object_name: Ketosis


subject: CHEBI:17087

object_name: Ketoacidosis


subject: CHEBI:27732

subject_name: Caffeine


subject: CHEBI:27732


subject: CHEBI:27732


subject: PUBCHEM.COMPOUND:20734893

subject_name: Fluticasone furoate

object_name: perennial allergic rhinitis


subject: CHEBI:5134

subject_name: Fluticasone


subject: CHEBI:191205

subject_name: Phe-Phe


subject: CHEBI:74750

subject_name: Phe-Pro


subject: PR:000014563

subject_name: succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial


subject: CHEBI:94366

subject_name: itraconazole

object_name: respiratory syncytial virus infectious disease


subject: CHEBI:28593

subject_name: Quinidine


subject: CHEBI:3387

subject_name: Carbamazepine


subject: CHEBI:36080

subject_name: protein

object_name: HIV infection


subject: UMLS:C0033684

subject_name: Proteins


subject: PR:000000001


subject: UMLS:C3827171

object_name: glioblastoma


subject: UMLS:C3827171

object_name: Brain Stem Glioblastoma


subject: UMLS:C3827171

object_name: glioma susceptibility 1


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib


subject: PUBCHEM.COMPOUND:71226663


subject: PUBCHEM.COMPOUND:71226663


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: mantle cell lymphoma


subject: UNII:AG9MHG098Z

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:AG9MHG098Z

object_name: non-Hodgkin lymphoma


subject: CHEBI:233364

subject_name: Bryostatin

object_name: multiple sclerosis


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: UNII:AV9K9X720D

object_name: coccidioidomycosis


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: Postoperative retention of urine


subject: PUBCHEM.COMPOUND:74030550

object_name: Postprocedural retention of urine


subject: CHEBI:7772

subject_name: omeprazole

object_name: central serous chorioretinopathy


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: UMLS:C4727717

subject_name: TAR 200

object_name: superficial urinary bladder carcinoma


subject: CHEBI:229213

subject_name: Elacestrant

object_name: Childhood Breast Carcinoma


subject: CHEBI:229213

object_name: breast carcinoma


subject: CHEBI:229213

object_name: breast cancer


subject: CHEBI:229213

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: CHEBI:6931

subject_name: Midazolam

object_name: Agitation, CTCAE 3.0


subject: CHEBI:6931

object_name: Agitation


subject: CHEBI:6931

object_name: Agitation, CTCAE 5.0


subject: UNII:T432289GYZ

subject_name: Sinecatechins

object_name: bladder tumor


subject: UNII:T432289GYZ

object_name: urinary bladder carcinoma


subject: UNII:T432289GYZ

object_name: urinary bladder cancer


subject: UNII:T432289GYZ

object_name: childhood bladder carcinoma


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: ulcerative colitis


subject: CHEBI:17650

object_name: inflammatory bowel disease 1


subject: CHEBI:17650

object_name: inflammatory bowel disease


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Cancer of brain and nervous system


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: UMLS:C4727312

subject_name: 6 Melanoma Helper Peptide Vaccine

object_name: melanoma


subject: PUBCHEM.COMPOUND:136033680

subject_name: Poly(ICLC)


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:WJA5UO9E10

subject_name: Orelabrutinib

object_name: neuromyelitis optica


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: diabetic retinopathy


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:8802

subject_name: Remifentanil

object_name: stroke disorder


subject: CHEBI:8802

object_name: cerebrovascular disorder


subject: CHEBI:8802

object_name: Stroke (heart beat)


subject: CHEBI:8802

object_name: Stroke, CTCAE


subject: PUBCHEM.COMPOUND:9794806

subject_name: HUPERZINE A

object_name: Alzheimer disease


subject: CHEBI:178022

subject_name: huperzine A(1+)


subject: CHEBI:231605

subject_name: Telaglenastat

object_name: pulmonary hypertension


subject: CHEBI:231605

object_name: Pulmonary Hypertension, CTCAE


subject: UNII:2S9ZZM9Q9V

object_name: neuroendocrine carcinoma


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:499361

subject_name: Aprepitant

object_name: Vomiting


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Parkinson disease


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:63632

subject_name: Topotecan

object_name: cancer


subject: CHEBI:63632

object_name: neoplasm


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: Sepsis


subject: UNII:T42P99266K

object_name: Sepsis, CTCAE


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:43830


subject: CHEBI:16480

subject_name: Nitric Oxide


subject: CHEBI:16480


subject: UMLS:C0962190

object_name: Neoplasms, Experimental


subject: UMLS:C0962190


subject: UMLS:C0962190

object_name: Adult Solid Neoplasm


subject: UMLS:C0962190

object_name: adult lymphoma


subject: UMLS:C0962190

object_name: lymphoma


subject: UMLS:C0962190

object_name: pediatric lymphoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Regional anesthesia morbidity


subject: UMLS:C0360094

subject_name: iv lidocaine


subject: UMLS:C3502775

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib


subject: CHEBI:3139

subject_name: bleomycin

object_name: Hodgkin Disease


subject: CHEBI:3139

object_name: Adult Classical Hodgkin Lymphoma


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:71417

subject_name: Procarbazine


subject: CHEBI:71417


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: UMLS:C5555594

subject_name: Lutetium Lu-177 PNT2002

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:44915

subject_name: Propofol

object_name: ovarian cancer


subject: CHEBI:44915

object_name: ovarian neoplasm


subject: CHEBI:44915

object_name: ovarian carcinoma


subject: CHEBI:44915

object_name: lung cancer


subject: CHEBI:44915

object_name: lung neoplasm


subject: CHEBI:44915

object_name: lung carcinoma


subject: CHEBI:44915

object_name: liver cancer


subject: CHEBI:44915

object_name: liver neoplasm


subject: CHEBI:44915

object_name: Adult Liver Carcinoma


subject: CHEBI:44915

object_name: liver carcinoma


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: UNII:N673F6W2VH

subject_name: Odanacatib

object_name: Childhood Breast Carcinoma


subject: UNII:N673F6W2VH

object_name: breast carcinoma


subject: UNII:N673F6W2VH

object_name: breast cancer


subject: PUBCHEM.COMPOUND:71544787

subject_name: fosnetupitant

object_name: Chemotherapy-induced nausea and vomiting


subject: PUBCHEM.COMPOUND:71544787

object_name: Nausea post chemotherapy


subject: CHEBI:85155

subject_name: Netupitant


subject: UNII:YZS3R7LP44

subject_name: Palonosetron


subject: UNII:YZS3R7LP44


subject: UMLS:C3642443

object_name: Solid Neoplasm


subject: CHEBI:83766

subject_name: Olaparib

object_name: Childhood Solid Neoplasm


subject: CHEBI:83766

object_name: Adult Solid Neoplasm


subject: CHEBI:83766


subject: PUBCHEM.COMPOUND:9960701

subject_name: NuvaRing

object_name: Encounter due to In vitro fertilization


subject: PUBCHEM.COMPOUND:9960701

object_name: infertility


subject: CHEBI:8871

subject_name: Risperidone

object_name: schizotypal personality disorder


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: Chronic Lymphocytic Leukemia- Binet Staging System


subject: PR:000023576

subject_name: phosphoenolpyruvate carboxylase

object_name: non-Hodgkin lymphoma


subject: CHEBI:74947

subject_name: Thalidomide


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: EXCESS LMW-DNA


subject: UNII:4118932Z90

subject_name: TRELAGLIPTIN SUCCINATE

object_name: type 2 diabetes mellitus


subject: UMLS:C4045913

subject_name: trelagliptin succinate


subject: CHEBI:64073

object_name: Hypothalamic obesity


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UMLS:C3489432

object_name: Parkinson disease


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: colorectal cancer


subject: UNII:1C6V77QF41

object_name: colorectal carcinoma


subject: UNII:1C6V77QF41

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: PUBCHEM.COMPOUND:6917964

subject_name: OCTREOTIDE ACETATE

object_name: constipation, impaction, and bowel obstruction


subject: PUBCHEM.COMPOUND:6917964

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:6917964

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:6917964

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:6917964

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:6917964

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:6917964

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:6917964

object_name: Stomach cancer


subject: PUBCHEM.COMPOUND:6917964

object_name: gastric cancer


subject: PUBCHEM.COMPOUND:6917964

object_name: small intestine cancer


subject: PUBCHEM.COMPOUND:6917964

object_name: small intestine carcinoma


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964

object_name: extrahepatic bile duct carcinoma


subject: PUBCHEM.COMPOUND:6917964

object_name: malignant tumor of extrahepatic bile duct


subject: PUBCHEM.COMPOUND:6917964

object_name: peritoneum cancer


subject: PUBCHEM.COMPOUND:6917964

object_name: Plexosarcoma


subject: PUBCHEM.COMPOUND:6917964

object_name: Nausea and vomiting


subject: CHEBI:7726

subject_name: octreotide


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726

object_name: colorectal cancer


subject: CHEBI:7726

object_name: colorectal carcinoma


subject: CHEBI:7726

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:173763

subject_name: Thermophillin

object_name: methamphetamine dependence


subject: PUBCHEM.COMPOUND:23597337

subject_name: Physalin L


subject: CHEBI:4659

subject_name: Disulfiram


subject: CHEBI:50091

subject_name: S-Nitrosoglutathione

object_name: bronchopulmonary dysplasia


subject: CHEBI:50091

object_name: Bronchopulmonary Dysplasia, AE


subject: CHEBI:27306

subject_name: vitamin B6

object_name: Hot Flashes, CTCAE


subject: CHEBI:27306

object_name: Hot flashes


subject: CHEBI:27306

object_name: prostate carcinoma


subject: UNII:3FTR44B32Q

object_name: gingivitis


subject: UNII:3FTR44B32Q

object_name: gingival disorder


subject: CHEBI:135933

subject_name: Tin Fluorides


subject: CHEBI:71029

subject_name: Ser-Phe


subject: CHEBI:71029


subject: UMLS:C0876942

subject_name: SF Brand of Topical Fluoride


subject: UMLS:C0876942


subject: PR:000008534

subject_name: hepatocyte growth factor


subject: PR:000008534


subject: CHEBI:3242

subject_name: butorphanol

object_name: pain agnosia


subject: CHEBI:3242

object_name: Pain insensitivity


subject: CHEMBL.COMPOUND:CHEMBL3545220

object_name: migraine


subject: UMLS:C0301532

subject_name: Multivitamin preparation

object_name: malnutrition


subject: UMLS:C0556112

subject_name: Mineral supplements


subject: PUBCHEM.COMPOUND:45380979

subject_name: RONICICLIB

object_name: small cell lung carcinoma


subject: UMLS:C2985188


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: psychosis


subject: UMLS:C0085297

object_name: Nonorganic psychosis


subject: UMLS:C0085297

object_name: Psychosis, CTCAE


subject: UMLS:C0085297

object_name: autoimmune encephalitis


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:9168

object_name: stage IV pancreatic cancer


subject: CHEBI:9168

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:9168

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:9168

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:9168

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:9168

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:66903

subject_name: Vismodegib


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:230873

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:93755


subject: UMLS:C2703137


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: High grade glioma


subject: CHEBI:72564

subject_name: Temozolomide


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: Blood Pressure Finding


subject: UNII:C8ADC441ME

object_name: Systemic arterial pressure


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6904


subject: UMLS:C3467818

object_name: Alzheimer disease


subject: UMLS:C5400018

subject_name: Defibrotide, Pig

object_name: graft versus host disease


subject: UNII:438HCF2X0M

subject_name: Defibrotide


subject: CHEBI:94805

subject_name: Ataluren

object_name: Duchenne muscular dystrophy


subject: UMLS:C1869204

subject_name: PTC 124


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: diabetes mellitus


subject: CHEBI:31348

subject_name: Capecitabine

object_name: peritoneal carcinomatosis


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:T41737F88A

subject_name: Tisotumab vedotin

object_name: cervical cancer


subject: UNII:T41737F88A

object_name: cervical carcinoma


subject: UMLS:C3827178

subject_name: HuMax-TF-ADC


subject: UMLS:C3827178


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: primary biliary cholangitis


subject: CHEBI:8707

subject_name: Quetiapine

object_name: fibromyalgia


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: nasopharyngeal carcinoma


subject: MESH:C079198

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:4708

subject_name: Doxazosin

object_name: adrenal gland pheochromocytoma


subject: CHEBI:4708

object_name: pheochromocytoma


subject: CHEBI:8077

subject_name: Phenoxybenzamine


subject: CHEBI:8077


subject: CHEBI:74705

subject_name: Met-Leu

object_name: opiate dependence


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C5205926

subject_name: Zeluvalimab

object_name: acute lymphoblastic leukemia


subject: UMLS:C4331948

object_name: schizophrenia


subject: CHEBI:95165

object_name: Leukaemia recurrent


subject: CHEBI:95165

object_name: complications of organ transplant stem cells


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: UMLS:C0003442


subject: CHEBI:53311

subject_name: sodium alginate

object_name: Dyssomnias


subject: CHEBI:53311

object_name: Sleep abnormality


subject: CHEBI:53311

object_name: sleep disorder


subject: PUBCHEM.COMPOUND:131704328

subject_name: Alginic acid


subject: PUBCHEM.COMPOUND:131704328


subject: PUBCHEM.COMPOUND:131704328


subject: CHEMBL.COMPOUND:CHEMBL2108744

subject_name: SODIUM ALGINATE


subject: CHEMBL.COMPOUND:CHEMBL2108744


subject: CHEMBL.COMPOUND:CHEMBL2108744


subject: UNII:JL7V54Z2BR

subject_name: Aspacytarabine

object_name: acute myeloid leukemia by FAB classification


subject: UNII:JL7V54Z2BR

object_name: acute myeloid leukemia


subject: UNII:JL7V54Z2BR


subject: UMLS:C4727173


subject: UMLS:C4727173


subject: UMLS:C4727173


subject: PUBCHEM.COMPOUND:2269

object_name: chronic obstructive pulmonary disease


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:72297

subject_name: Lomitapide


subject: UNII:8A7F670F2Y

subject_name: Sacrosidase

object_name: short bowel syndrome


subject: UMLS:C0038634

subject_name: SUCRASE


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: mild neurocognitive disorder


subject: UMLS:C0358855

object_name: mild cognitive impairment


subject: CHEBI:231679

subject_name: ipilimumab

object_name: uveal melanoma


subject: CHEBI:231679

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:50692

subject_name: Mifepristone

object_name: adrenal gland hyperfunction


subject: CHEBI:50692

object_name: type 2 diabetes mellitus


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG


subject: CHEBI:7931

subject_name: Paricalcitol


subject: UMLS:C3900197

subject_name: 5-FITC-labeled Colon-Heptapeptide

object_name: polyp of colon


subject: UMLS:C3900197

object_name: inflammatory bowel disease


subject: UMLS:C3900197

object_name: colorectal cancer


subject: UMLS:C3900197

object_name: colorectal carcinoma


subject: UMLS:C3900197

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: DRUGBANK:DB16536

subject_name: Birch bark extract

object_name: Traumatic Wound


subject: UMLS:C5669860


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: liver cirrhosis


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: CHEBI:149509

object_name: chronic kidney disease


subject: CHEBI:149509

object_name: Chronic uremia


subject: CHEBI:149509

object_name: cardiovascular disorder


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:3347


subject: CHEBI:3347


subject: PUBCHEM.COMPOUND:3222


subject: PUBCHEM.COMPOUND:3222


subject: PUBCHEM.COMPOUND:3222


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:4784


subject: CHEBI:4784


subject: DRUGBANK:DB14362

subject_name: Moringa oleifera leaf

object_name: dental caries


subject: DRUGBANK:DB14362

object_name: Dental Caries, CTCAE


subject: CHEBI:24757

subject_name: Hypochlorite


subject: CHEBI:24757


subject: CHEBI:24757

object_name: dental pulp necrosis


subject: CHEBI:33353

subject_name: technetium atom

object_name: rheumatoid arthritis


subject: UNII:G6S5600O0D

object_name: Regional Neuroblastoma


subject: UNII:G6S5600O0D

object_name: Neuroblastoma recurrent


subject: UNII:G6S5600O0D

object_name: Disseminated neuroblastoma


subject: UNII:G6S5600O0D

object_name: Stage 4S neuroblastoma


subject: UNII:G6S5600O0D

object_name: Localized Unresectable Neuroblastoma


subject: UNII:82MI0GT75Z

object_name: arteriosclerosis disorder


subject: UNII:82MI0GT75Z

object_name: atherosclerosis


subject: MESH:C526315


subject: MESH:C526315


subject: UMLS:C5555578

object_name: melanoma


subject: UMLS:C5555578

object_name: non-small cell lung carcinoma


subject: UMLS:C5783829

subject_name: Anti-SIRPa Monoclonal Antibody BI 770371


subject: UMLS:C5783829


subject: UNII:5V1UI86573

subject_name: EZABENLIMAB


subject: UNII:5V1UI86573


subject: UMLS:C4329334

subject_name: Ezabenlimab


subject: UMLS:C4329334


subject: UMLS:C5557679

subject_name: Oncofid-P-B

object_name: Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7


subject: CHEBI:229236

subject_name: Fezolinetant

object_name: kidney failure


subject: UMLS:C2348115

subject_name: SN-38-Loaded Polymeric Micelles NK012

object_name: triple-negative breast carcinoma


subject: UMLS:C2348115

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:6959

subject_name: Mivacurium chloride

object_name: no feeling or sensation of skin


subject: CHEBI:6959

object_name: Sensory Loss


subject: UNII:600ZG213C3

subject_name: MIVACURIUM CHLORIDE


subject: UNII:600ZG213C3


subject: CHEBI:6958

subject_name: Mivacurium


subject: CHEBI:6958


subject: CHEBI:90841

subject_name: Cangrelor

object_name: Hemorrhage


subject: CHEBI:90841

object_name: coronary artery disorder


subject: CHEBI:90841

object_name: coronary atherosclerosis


subject: CHEBI:90841

object_name: myocardial infarction


subject: CHEBI:90841

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:90841

object_name: Myocardial Infarction by ECG Finding


subject: UNII:98DE7VN88D

subject_name: huMov 19


subject: UMLS:C3640818


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody

object_name: pancreatic neoplasm


subject: UMLS:C4289970

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4289970

object_name: malignant pancreatic neoplasm


subject: UMLS:C3872072

subject_name: ferric pyrophosphate liposomal

object_name: chronic kidney disease


subject: UMLS:C5203331

subject_name: Iron Dextran Injection


subject: UMLS:C0309328

subject_name: Injectable iron dextran


subject: CHEBI:18248

subject_name: Iron


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin


subject: PR:000009978

subject_name: lactotransferrin


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: UMLS:C0056151

subject_name: Combizym

object_name: polyp of colon


subject: CHEBI:94793

subject_name: Pimasertib

object_name: cancer


subject: UNII:8570LZ3RCA


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: diabetic retinopathy


subject: UNII:ZL1R02VT79

object_name: Retinal neovascularization


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: bladder tumor


subject: UNII:PQX0D8J21J

object_name: urinary bladder carcinoma


subject: UNII:PQX0D8J21J

object_name: urinary bladder cancer


subject: UNII:PQX0D8J21J

object_name: childhood bladder carcinoma


subject: UNII:PQX0D8J21J

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:PQX0D8J21J

object_name: HER2 protein overexpression


subject: UNII:PQX0D8J21J

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: UNII:PQX0D8J21J

object_name: endometrial cancer


subject: UNII:PQX0D8J21J

object_name: endometrial carcinoma


subject: UNII:PQX0D8J21J

object_name: HER2 positive breast carcinoma


subject: UNII:PQX0D8J21J

object_name: HER2-positive gastric cancer


subject: UNII:PQX0D8J21J

object_name: triple-negative breast carcinoma


subject: UNII:PQX0D8J21J

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: Disseminated Malignant Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: Embolism, Tumor


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: Neoplasm Metastasis


subject: CHEMBL.COMPOUND:CHEMBL4650287


subject: CHEMBL.COMPOUND:CHEMBL4650287


subject: CHEMBL.COMPOUND:CHEMBL4650287


subject: CHEMBL.COMPOUND:CHEMBL4650287


subject: CHEMBL.COMPOUND:CHEMBL4650287


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: exocrine pancreatic carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: malignant pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: ovarian neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: HER2 protein overexpression


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: cervical cancer


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: cervical carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: carcinoma of esophagus


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: esophageal cancer


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: Childhood Esophageal Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: neoplasm of esophagus


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: colorectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: endometrial cancer


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: endometrial carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: HER2 positive breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: HER2-positive gastric cancer


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: head and neck squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: triple-negative breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: Triple-Negative Breast Cancer Finding


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: malignant soft tissue neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: sarcoma


subject: CHEBI:231601

subject_name: trastuzumab

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:231601

object_name: Embolism, Tumor


subject: CHEBI:231601

object_name: Neoplasm Metastasis


subject: CHEBI:231601

object_name: HER2 protein overexpression


subject: CHEBI:231601

object_name: cervical cancer


subject: CHEBI:231601

object_name: cervical carcinoma


subject: CHEBI:231601

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C4489845

subject_name: CANNABIDIOL OIL

object_name: mild neurocognitive disorder


subject: UMLS:C4489845

object_name: mild cognitive impairment


subject: CHEBI:1457

subject_name: Tramiprosate


subject: CHEBI:1457


subject: UMLS:C0062961

subject_name: tramiprosate


subject: UMLS:C0062961


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: substance abuse


subject: CHEBI:7459

subject_name: Naloxone


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: retinal degeneration


subject: UNII:15C2VL427D

object_name: eye disorder


subject: CHEBI:233453

object_name: herpes simplex virus gingivostomatitis


subject: CHEBI:35854

subject_name: Valaciclovir


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: Disorder due to radiotherapy


subject: PUBCHEM.COMPOUND:18772499

object_name: endometrium neoplasm


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C2183198


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:27991

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:27991

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:27991

object_name: Rectal hemorrhage


subject: PUBCHEM.COMPOUND:27991

object_name: Hematochezia


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: PUBCHEM.COMPOUND:16051933


subject: PUBCHEM.COMPOUND:16051933


subject: PUBCHEM.COMPOUND:16051933


subject: PUBCHEM.COMPOUND:16051933


subject: CHEBI:232606

subject_name: Emrusolmin

object_name: Parkinson disease


subject: CHEBI:177298

object_name: breast neoplasm


subject: CHEBI:176844

subject_name: Niraparib


subject: PUBCHEM.COMPOUND:20751579

object_name: influenza


subject: CHEBI:134741

subject_name: laninamivir


subject: UNII:37KZM6S21G

subject_name: cerebrolysin

object_name: Cognitive impairment


subject: UMLS:C0055108


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: rheumatoid arthritis


subject: CHEBI:231350

subject_name: Pacritinib


subject: CHEBI:231350

object_name: Post-polycythemia vera myelofibrosis


subject: CHEBI:231350

object_name: myelofibrosis


subject: UMLS:C5565362

subject_name: HIPRA COVID-19 vaccine


subject: UMLS:C5565362

object_name: SARS-CoV-2 acute respiratory disease


subject: CHEMBL.COMPOUND:CHEMBL5314974

object_name: interstitial lung disease


subject: CHEMBL.COMPOUND:CHEMBL5314974

object_name: chronic kidney disease


subject: UMLS:C5853404


subject: UMLS:C5853404


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: diffuse large B-cell lymphoma


subject: UNII:D6OMY2L0WA

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:D6OMY2L0WA

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C5206892

subject_name: epcoritamab


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C3813201

subject_name: Oral Rehydration Solution OS-1

object_name: biliary tract cancer


subject: UMLS:C3813201

object_name: liver carcinoma


subject: UMLS:C0078516

subject_name: World Health Organization oral rehydration solution


subject: UMLS:C0078516


subject: UMLS:C1443923

subject_name: Oral rehydration solution


subject: UMLS:C1443923


subject: MESH:C034130

subject_name: ORALIT


subject: MESH:C034130


subject: CHEBI:27375

subject_name: Vinblastine

object_name: glioma


subject: CHEBI:27375

object_name: malignant glioma


subject: UNII:1351PE5UGS

subject_name: Elotuzumab

object_name: Plasma cell myeloma refractory


subject: CHEBI:567361

subject_name: Cladribine

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:567361

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:567361

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:567361

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:567361

object_name: acute biphenotypic leukemia


subject: CHEBI:567361

object_name: Infant Acute Biphenotypic Leukemia


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: UMLS:C3834216

subject_name: Afrezza

object_name: type 2 diabetes mellitus


subject: UMLS:C3834216

object_name: type 1 diabetes mellitus 1


subject: UMLS:C3834216

object_name: type 1 diabetes mellitus


subject: UMLS:C5962489

subject_name: Anti-CD24/Anti-4-1BB Bispecific Monoclonal Antibody IBD0333

object_name: metatropic dysplasia


subject: UMLS:C5201181

subject_name: H.P. acthar gel

object_name: end stage renal failure


subject: UMLS:C5201181

object_name: Chronic uremia


subject: UMLS:C3265002

subject_name: avocado oil

object_name: Breast Feeding, Exclusive


subject: DRUGBANK:DB10504

subject_name: Avocado


subject: UMLS:C1366001

subject_name: Avocado preparation


subject: UNII:721809WQCP

subject_name: Ruboxistaurin

object_name: diabetic retinopathy


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:30314

object_name: metabolic syndrome X


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:43796


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Parkinson disease


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Corneal pannus


subject: CHEBI:5494

subject_name: ritropirronium bromide

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:5494

object_name: COPD, severe early onset


subject: UMLS:C2974205


subject: UMLS:C2974205


subject: CHEBI:90962

subject_name: Utibron Neohaler


subject: CHEBI:90962


subject: MESH:C000618615

subject_name: Fluzone High-Dose

object_name: influenza


subject: UNII:W6I5QDT7QI

subject_name: Netarsudil

object_name: Fuchs' endothelial dystrophy


subject: UNII:LA88IH4O02

subject_name: Mezigdomide

object_name: Hepatic impairment


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: neoplasm


subject: UMLS:C5205034


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: cytomegalovirus infection


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: CHEBI:8382

subject_name: Prednisone


subject: PUBCHEM.COMPOUND:20802597

subject_name: Sapacitabine

object_name: non-small cell lung carcinoma


subject: UMLS:C0042210

subject_name: Vaccines

object_name: HIV infection


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: CHEBI:63610

subject_name: Misoprostol

object_name: IUD insertion complication


subject: UMLS:C0042210


subject: UMLS:C5399710


subject: UNII:75FBL12IZ7

object_name: cancer


subject: UNII:75FBL12IZ7


subject: UNII:75FBL12IZ7

object_name: Childhood Breast Carcinoma


subject: UNII:75FBL12IZ7

object_name: breast carcinoma


subject: UNII:75FBL12IZ7

object_name: breast cancer


subject: UNII:75FBL12IZ7

object_name: Neck Carcinoma


subject: UNII:75FBL12IZ7

object_name: head and neck neoplasm


subject: UNII:75FBL12IZ7

object_name: head and neck cancer


subject: UNII:75FBL12IZ7

object_name: triple-negative breast carcinoma


subject: UNII:75FBL12IZ7

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:75FBL12IZ7

object_name: adult lymphoma


subject: UNII:75FBL12IZ7

object_name: lymphoma


subject: UNII:75FBL12IZ7

object_name: pediatric lymphoma


subject: UNII:75FBL12IZ7

object_name: melanoma


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C5238519

subject_name: Commensal Bacterial Strain Formulation VE800

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5238519

object_name: Embolism, Tumor


subject: UMLS:C5238519

object_name: Neoplasm Metastasis


subject: UMLS:C5238519

object_name: Stomach cancer


subject: UMLS:C5238519

object_name: gastric cancer


subject: UMLS:C5238519

object_name: colorectal cancer


subject: UMLS:C5238519

object_name: colorectal carcinoma


subject: UMLS:C5238519

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5238519


subject: UMLS:C5238519


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:15365

subject_name: Aspirin

object_name: Coronavinae infectious disease


subject: CHEBI:15365

object_name: severe acute respiratory syndrome


subject: CHEBI:23359

subject_name: colchicine


subject: CHEBI:23359


subject: UMLS:C0751599

subject_name: Betantrone


subject: UMLS:C0751599


subject: UMLS:C0015980

subject_name: interferon-beta


subject: UMLS:C0015980


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: CHEBI:68579


subject: CHEBI:135697

subject_name: Sarpogrelate

object_name: arteriosclerosis disorder


subject: CHEBI:135697

object_name: atherosclerosis


subject: UMLS:C5706500

subject_name: Anti-HER2 Monoclonal Antibody BAT1006

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:889I657R9P

subject_name: Desmethylsibutramine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:889I657R9P

object_name: obesity


subject: UNII:889I657R9P

object_name: Obesity, CTCAE


subject: UNII:987R943R3P

subject_name: Didesmethylsibutramine


subject: UNII:987R943R3P


subject: UNII:987R943R3P


subject: CHEBI:9137

subject_name: Sibutramine


subject: CHEBI:9137


subject: CHEBI:9137


subject: CHEBI:6413

subject_name: Letrozole

object_name: female infertility


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: brain small vessel disease 3


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: DRUGBANK:DB01404

subject_name: Ginseng

object_name: malignant neoplasm of breast stage I


subject: DRUGBANK:DB01404

object_name: Stage IB Breast Cancer AJCC v7


subject: DRUGBANK:DB01404

object_name: Stage IA Breast Cancer AJCC v7


subject: DRUGBANK:DB01404

object_name: Stage II Colon Cancer AJCC v7


subject: DRUGBANK:DB01404

object_name: Stage III Breast Cancer AJCC v7


subject: DRUGBANK:DB01404

object_name: Stage III Colon Cancer AJCC v7


subject: DRUGBANK:DB01404

object_name: Stage IIA Colon Cancer AJCC v7


subject: DRUGBANK:DB01404

object_name: Stage IIC Colon Cancer AJCC v7


subject: DRUGBANK:DB01404

object_name: Stage IIB Colon Cancer AJCC v7


subject: DRUGBANK:DB01404

object_name: Stage IIIC Breast Cancer AJCC v7


subject: DRUGBANK:DB01404

object_name: Stage IIIA Breast Carcinoma


subject: DRUGBANK:DB01404

object_name: Stage IIIB Breast Carcinoma


subject: DRUGBANK:DB01404

object_name: Stage IIIC Colon Cancer AJCC v7


subject: DRUGBANK:DB01404

object_name: Stage IIIB Colon Cancer AJCC v7


subject: DRUGBANK:DB01404

object_name: Stage IIIA Colon Cancer AJCC v7


subject: DRUGBANK:DB01404

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: DRUGBANK:DB01404

object_name: Stage I Colon Cancer AJCC v6 and v7


subject: DRUGBANK:DB01404

object_name: Stage IIB Breast Carcinoma


subject: DRUGBANK:DB01404

object_name: Stage IIA Breast Carcinoma


subject: DRUGBANK:DB14296

subject_name: Panax quinquefolius whole

object_name: malignant neoplasm of breast stage I


subject: DRUGBANK:DB14296

object_name: Stage IB Breast Cancer AJCC v7


subject: DRUGBANK:DB14296

object_name: Stage IA Breast Cancer AJCC v7


subject: DRUGBANK:DB14296

object_name: Stage II Colon Cancer AJCC v7


subject: DRUGBANK:DB14296

object_name: Stage III Breast Cancer AJCC v7


subject: DRUGBANK:DB14296

object_name: Stage III Colon Cancer AJCC v7


subject: DRUGBANK:DB14296

object_name: Stage IIA Colon Cancer AJCC v7


subject: DRUGBANK:DB14296

object_name: Stage IIC Colon Cancer AJCC v7


subject: DRUGBANK:DB14296

object_name: Stage IIB Colon Cancer AJCC v7


subject: DRUGBANK:DB14296

object_name: Stage IIIC Breast Cancer AJCC v7


subject: DRUGBANK:DB14296

object_name: Stage IIIA Breast Carcinoma


subject: DRUGBANK:DB14296

object_name: Stage IIIB Breast Carcinoma


subject: DRUGBANK:DB14296

object_name: Stage IIIC Colon Cancer AJCC v7


subject: DRUGBANK:DB14296

object_name: Stage IIIB Colon Cancer AJCC v7


subject: DRUGBANK:DB14296

object_name: Stage IIIA Colon Cancer AJCC v7


subject: DRUGBANK:DB14296

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: DRUGBANK:DB14296

object_name: Stage I Colon Cancer AJCC v6 and v7


subject: DRUGBANK:DB14296

object_name: Stage IIB Breast Carcinoma


subject: DRUGBANK:DB14296

object_name: Stage IIA Breast Carcinoma


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: Aspirin exacerbated respiratory disease


subject: UMLS:C3658854


subject: UMLS:C2934919

object_name: inherited lipid metabolism disorder


subject: UMLS:C2934919

object_name: Dyslipidemia


subject: UMLS:C2934919

object_name: coronary artery disorder


subject: UMLS:C2934919

object_name: coronary atherosclerosis


subject: CHEBI:521033

subject_name: Dutasteride

object_name: salivary duct carcinoma


subject: CHEBI:5523

subject_name: Goserelin


subject: CHEBI:144094

subject_name: bicalutamide


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Blood Loss


subject: CHEBI:28918

object_name: Hemorrhage


subject: UMLS:C5706542

subject_name: Anti-B7-H4 ADC XMT-1660

object_name: peritoneum cancer


subject: UMLS:C5706542

object_name: triple-negative breast carcinoma


subject: UMLS:C5706542

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5706542

object_name: adrenal cortex carcinoma


subject: UMLS:C5706542

object_name: adenoid cystic carcinoma


subject: UMLS:C5706542

object_name: fallopian tube carcinoma


subject: UMLS:C5706542

object_name: fallopian tube cancer


subject: UMLS:C5706542

object_name: endometrial cancer


subject: UMLS:C5706542

object_name: uterine corpus cancer


subject: UMLS:C5706542

object_name: endometrial carcinoma


subject: UMLS:C5706542

object_name: ovarian cancer


subject: UMLS:C5706542

object_name: ovarian neoplasm


subject: UMLS:C5706542

object_name: ovarian carcinoma


subject: UMLS:C5706542

object_name: Childhood Breast Carcinoma


subject: UMLS:C5706542

object_name: breast carcinoma


subject: UMLS:C5706542

object_name: breast cancer


subject: CHEBI:95165

object_name: cancer


subject: CHEBI:95165

object_name: neoplasm


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: UNII:DB1041CXDG

subject_name: BELANTAMAB

object_name: Autoimmunity


subject: UMLS:C5399232

subject_name: belantamab


subject: CHEBI:32599

object_name: Maternity blues


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:67194

subject_name: Nabiximols

object_name: chronic kidney disease


subject: CHEBI:67194

object_name: cannabis abuse


subject: PUBCHEM.COMPOUND:53481562

subject_name: Gonadotropin-Releasing Hormone

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:53481562

object_name: prostate cancer


subject: CHEBI:5520

subject_name: gonadorelin


subject: CHEBI:5520


subject: PR:000008127


subject: PR:000008127


subject: UMLS:C0306166

subject_name: Factrel


subject: UMLS:C0306166


subject: CHEBI:135949

subject_name: Ambrisentan

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:135949

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:135949

object_name: pulmonary arterial hypertension


subject: GTOPDB:13453

subject_name: dazodalibep

object_name: Sicca Syndrome


subject: CHEMBL.COMPOUND:CHEMBL4594331

subject_name: DAZODALIBEP


subject: UMLS:C5446692

subject_name: Dazodalibep


subject: UMLS:C3177398

subject_name: DLBS 1033

object_name: type 2 diabetes mellitus


subject: UMLS:C3177398

object_name: Diabetes


subject: UMLS:C3177398

object_name: diabetes mellitus


subject: UMLS:C3177398

object_name: peripheral vascular disease


subject: UMLS:C3177398

object_name: peripheral arterial disease


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: gastroesophageal cancer


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: adult lymphoma


subject: CHEBI:201431

object_name: lymphoma


subject: CHEBI:201431

object_name: pediatric lymphoma


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: UMLS:C0164196

subject_name: GUM MASTIC PREPARATION

object_name: Nonulcer dyspepsia


subject: CHEBI:6801

subject_name: Metformin

object_name: chronic kidney disease


subject: CHEBI:6801

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:6801

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Globus Hystericus


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: cardiac sarcoidosis


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: metastatic malignant neoplasm in the brain


subject: GTOPDB:9592

object_name: Metastatic non-small cell lung cancer


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:80270

object_name: coronary artery disorder


subject: CHEBI:80270

object_name: coronary atherosclerosis


subject: CHEBI:80270

object_name: type 2 diabetes mellitus


subject: CHEBI:80270

object_name: maturity-onset diabetes of the young type 1


subject: UNII:2XLN4Y044H

subject_name: REGADENOSON


subject: UNII:2XLN4Y044H


subject: PUBCHEM.COMPOUND:22451303

subject_name: Regadenoson


subject: PUBCHEM.COMPOUND:22451303


subject: PUBCHEM.COMPOUND:5150939

subject_name: Lucerastat

object_name: Fabry disease


subject: RXCUI:151539

subject_name: Combivent

object_name: chronic obstructive pulmonary disease


subject: UNII:5ZHA5P4PFX

subject_name: Dalpiciclib

object_name: Childhood Breast Carcinoma


subject: UNII:5ZHA5P4PFX

object_name: breast carcinoma


subject: UNII:5ZHA5P4PFX

object_name: breast cancer


subject: CHEBI:70707

subject_name: Vilazodone

object_name: separation anxiety disorder


subject: UMLS:C5564565

object_name: Ulcerative colitis, active moderate


subject: UMLS:C5564565

object_name: Ulcerative colitis, active severe


subject: PUBCHEM.COMPOUND:11422859

object_name: adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:11422859

object_name: childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:11422859

object_name: childhood acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:11422859

object_name: acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:11422859

object_name: adult acute lymphoblastic leukemia


subject: UMLS:C5907896

subject_name: MIN 102

object_name: adrenoleukodystrophy


subject: UMLS:C5907896

object_name: X-linked cerebral adrenoleukodystrophy


subject: CHEBI:167574

subject_name: Semaglutide

object_name: nicotine dependence


subject: CHEBI:167574

object_name: Nicotine Addiction


subject: UMLS:C5401619

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C4727211

subject_name: Milled Seed Mix

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C4727211

object_name: non-Hodgkin lymphoma


subject: UMLS:C4727211

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C4727211

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:10033

subject_name: Warfarin

object_name: thrombus due to heart valve prosthesis


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: adrenal gland pheochromocytoma


subject: CHEBI:4466

object_name: pheochromocytoma


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UMLS:C0017302

subject_name: General anesthetic drugs


subject: UMLS:C0017302


subject: UMLS:C3536928

subject_name: General Anesthetic [EPC]


subject: UMLS:C3536928


subject: CHEBI:135935

subject_name: Tapentadol

object_name: osteoarthritis, knee


subject: CHEBI:135935

object_name: osteoarthritis, hip


subject: CHEBI:135935

object_name: Low back pain


subject: CHEBI:157844

subject_name: Glu-Arg


subject: CHEBI:157844


subject: CHEBI:157844


subject: CHEBI:33379

subject_name: erbium


subject: CHEBI:33379


subject: CHEBI:33379


subject: UMLS:C5441529

subject_name: Estrogen Receptor Family, human


subject: UMLS:C5441529


subject: UMLS:C5441529


subject: PR:000007204

subject_name: estrogen receptor


subject: PR:000007204


subject: PR:000007204


subject: CHEMBL.COMPOUND:CHEMBL2108494

subject_name: INTERFERON

object_name: acute myeloid leukemia by FAB classification


subject: CHEMBL.COMPOUND:CHEMBL2108494

object_name: acute myeloid leukemia


subject: UMLS:C3652465

subject_name: Interferon


subject: UMLS:C3652465


subject: UMLS:C0021747

subject_name: Interferons


subject: UMLS:C0021747


subject: UMLS:C0733470

subject_name: human leukocyte interferon


subject: UMLS:C0733470


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: diabetic kidney disease


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: inflammatory spondylopathy


subject: CHEBI:25681

object_name: spondyloarthropathy


subject: CHEBI:25681

object_name: Polyarthritis


subject: UMLS:C0936245

subject_name: Ethiodized Poppy Seed Oil

object_name: female infertility


subject: UMLS:C2003373

object_name: deafness


subject: UMLS:C2003373

object_name: hearing loss by exam


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Adverse drug response


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:149601

subject_name: Bempedoic acid

object_name: hyperlipidemia


subject: CHEBI:57694

object_name: Problem of aging


subject: CHEBI:57694

object_name: stroke disorder


subject: CHEBI:57694

object_name: cerebrovascular disorder


subject: CHEBI:57694

object_name: Stroke (heart beat)


subject: CHEBI:57694

object_name: Stroke, CTCAE


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: CHEBI:16243


subject: CHEBI:16243


subject: CHEBI:16243


subject: CHEBI:3077

subject_name: Betamethasone

object_name: atopic eczema/dermatitis (non-specific)


subject: CHEBI:134677

subject_name: Crisaborole


subject: MESH:C000634027

object_name: Friedreich ataxia


subject: PUBCHEM.COMPOUND:11670360

subject_name: Nirogacestat

object_name: ovarian granulosa cell tumor


subject: PUBCHEM.COMPOUND:11670360

object_name: Adult Type Ovarian Granulosa Cell Tumor


subject: PUBCHEM.COMPOUND:11670360

object_name: Ovarian Granulosa-Stromal Cell Tumor


subject: PUBCHEM.COMPOUND:11670360

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:11670360

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:11670360

object_name: ovarian carcinoma


subject: CHEBI:188986

subject_name: idose

object_name: OPTN-related open angle glaucoma


subject: CHEBI:231347

subject_name: Triapine

object_name: Metastatic well-differentiated neuroendocrine tumor


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Acquired syphilis


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: MESH:C079198

subject_name: S 1 (combination)


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Acute Ischemic Stroke


subject: PUBCHEM.COMPOUND:54675783

object_name: Ischemic stroke


subject: CHEBI:4875

subject_name: Etanercept

object_name: chronic childhood arthritis


subject: CHEBI:4875

object_name: juvenile idiopathic arthritis


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: CHEBI:74705

subject_name: Met-Leu

object_name: relapsing-remitting multiple sclerosis


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: PUBCHEM.COMPOUND:145946918

subject_name: SPINOSAD

object_name: blepharitis


subject: CHEBI:6427

subject_name: Leuprolide

object_name: central precocious puberty


subject: CHEBI:17698

subject_name: Chloramphenicol

object_name: Chronic refractory cough


subject: CHEBI:17698

object_name: Unexplained chronic cough


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: endogenous depression


subject: CHEBI:9943

object_name: major depressive disorder


subject: CHEBI:10056

subject_name: Xanomeline

object_name: schizophrenia


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:5S371K6132

object_name: Adult Soft Tissue Sarcoma


subject: UNII:5S371K6132

object_name: sarcoma


subject: UNII:5S371K6132

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:5S371K6132

object_name: soft tissue sarcoma


subject: UMLS:C4547969

subject_name: apatinib mesylate


subject: UMLS:C4547969


subject: UMLS:C4547969


subject: UMLS:C4547969


subject: UMLS:C4547969


subject: CHEBI:94770

subject_name: Pirarubicin


subject: CHEBI:94770


subject: CHEBI:94770


subject: CHEBI:94770


subject: CHEBI:94770


subject: PUBCHEM.COMPOUND:13559282

subject_name: Ulipristal acetate

object_name: infertility


subject: CHEBI:71025

subject_name: ulipristal


subject: UMLS:C1170584

subject_name: Restasis

object_name: xerophthalmia


subject: UMLS:C1170584

object_name: dry eye syndrome


subject: UMLS:C1170584

object_name: Dry Eye Syndrome, CTCAE


subject: UMLS:C0445115

subject_name: Normal saline

object_name: metabolic disease


subject: UMLS:C0445115

object_name: childhood malignant neoplasm


subject: UMLS:C0445115

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UMLS:C0445115

object_name: aplastic anemia


subject: UMLS:C0445115

object_name: idiopathic aplastic anemia


subject: UNII:T3U32GLJ0F

subject_name: Difamilast

object_name: atopic eczema


subject: CHEBI:45924

subject_name: Trimethoprim

object_name: epidermolysis bullosa


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Ischemic stroke


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: UMLS:C5853676

object_name: myotonic dystrophy type 1


subject: UMLS:C5853676

object_name: myotonic dystrophy


subject: UMLS:C5853676

object_name: myotonic syndrome


subject: UMLS:C5853676

object_name: muscular dystrophy


subject: UMLS:C5853676

object_name: inherited neurodegenerative disorder


subject: UMLS:C5853676

object_name: genetic disease


subject: UMLS:C5853676

object_name: atrophic muscular disease


subject: UMLS:C5853676

object_name: neurodegenerative disease


subject: UMLS:C5853676

object_name: musculoskeletal system disorder


subject: UMLS:C5853676

object_name: nervous system disorder


subject: UMLS:C5853676

object_name: neuromuscular disease


subject: UMLS:C5853676

object_name: myopathy


subject: UMLS:C5853676

object_name: muscle tissue disorder


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: DNA Damage Response Deficiency


subject: UMLS:C3641122


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Duchenne and Becker muscular dystrophy


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:75722

subject_name: Tramadol

object_name: Acute Pain


subject: UNII:NU23Q531G1

subject_name: Catridecacog

object_name: Congenital Bleeding Disorder


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: schizophrenia


subject: CHEBI:138016

subject_name: MPA

object_name: progesterone receptor-negative breast cancer


subject: CHEBI:138016

object_name: estrogen receptor-negative breast cancer


subject: CHEBI:138016

object_name: Breast cancer recurrent


subject: CHEBI:138016

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:138016

object_name: Carcinoma breast stage IV


subject: CHEBI:138016

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:138016

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:17026


subject: CHEBI:17026


subject: CHEBI:17026


subject: CHEBI:17026


subject: CHEBI:17026


subject: CHEBI:17026


subject: CHEBI:6715

subject_name: medroxyprogesterone


subject: CHEBI:6715


subject: CHEBI:6715


subject: CHEBI:6715


subject: CHEBI:6715


subject: CHEBI:6715


subject: CHEBI:6715


subject: PR:000012478

subject_name: rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha


subject: PR:000012478


subject: PR:000012478


subject: PR:000012478


subject: PR:000012478


subject: PR:000012478


subject: PR:000012478


subject: UniProtKB:P27664

subject_name: PDE6A_MOUSE Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha (sprot)


subject: UniProtKB:P27664


subject: UniProtKB:P27664


subject: UniProtKB:P27664


subject: UniProtKB:P27664


subject: UniProtKB:P27664


subject: UniProtKB:P27664


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: UMLS:C2604746

object_name: Hypercholesterolemia


subject: UMLS:C2604746

object_name: hyperlipidemia


subject: UMLS:C2604746

object_name: hyperlipoproteinemia


subject: UMLS:C2604746

object_name: Hyperlipidemia, CTCAE


subject: UMLS:C2604746

object_name: Serum lipids high (finding)


subject: CHEBI:73024

subject_name: O-acetylcarnitine

object_name: outcomes general quality of life


subject: CHEBI:73024

object_name: Perceived quality of life


subject: CHEBI:73024

object_name: Good quality of life


subject: CHEBI:73024

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:73024

object_name: Fatigue


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: CHEBI:57589


subject: CHEBI:57589


subject: CHEBI:57589


subject: CHEBI:57589


subject: HMDB:HMDB0015332

subject_name: Rifapentine

object_name: tuberculosis


subject: CHEBI:63611

subject_name: Moxifloxacin


subject: CHEBI:45285

subject_name: Pyrazinamide


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage IIIC1 Uterine Corpus Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage IIIC2 Uterine Corpus Cancer AJCC v7


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: UNII:7SUP5O6AA1

object_name: Chronic cough


subject: UMLS:C1454298

subject_name: HKI 272

object_name: non-small cell lung carcinoma


subject: UMLS:C1454298

object_name: lung neoplasm


subject: CHEBI:61397

subject_name: Neratinib


subject: CHEBI:61397


subject: CHEBI:135923

subject_name: Migalastat

object_name: Fabry disease


subject: UMLS:C4547412

object_name: psoriatic arthritis


subject: CHEBI:132922

object_name: Fever


subject: CHEBI:132922

object_name: Fever symptoms (finding)


subject: CHEBI:132922

object_name: Fever, CTCAE


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: Pancreatic cancer, adult


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: CHEBI:175901

subject_name: Gemcitabine


subject: MESH:C079198

subject_name: S 1 (combination)


subject: CHEBI:80630

subject_name: Irinotecan

object_name: pancreatic ductal adenocarcinoma


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: digestive system neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: osteoarthritis, knee


subject: CHEBI:27306

subject_name: vitamin B6

object_name: colorectal cancer


subject: CHEBI:27306

object_name: colorectal carcinoma


subject: CHEBI:27306

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:939U7C91AI

subject_name: Solriamfetol

object_name: insomnia


subject: UNII:939U7C91AI

object_name: Insomnia, CTCAE 3.0


subject: UNII:939U7C91AI

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: chorioamnionitis


subject: CHEBI:28939

object_name: brain injury


subject: PUBCHEM.COMPOUND:3367

object_name: metastatic melanoma


subject: UNII:R1UQ6D1ECM

subject_name: ENTOLIMOD

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C2353146


subject: CHEBI:31654

subject_name: gliclazide

object_name: epilepsy


subject: CHEBI:201471

subject_name: Prochloraz Metabolite BTS 40348


subject: UMLS:C3846005

subject_name: Room Air

object_name: fetal hypoxia


subject: PUBCHEM.COMPOUND:11236066

subject_name: BRIMONIDINE TARTRATE

object_name: hand-foot syndrome


subject: PUBCHEM.COMPOUND:11236066

object_name: Sickle Cell Dactylitis


subject: CHEBI:3175

subject_name: Brimonidine


subject: CHEBI:3175


subject: CHEMBL.COMPOUND:CHEMBL2108758

subject_name: PEPPERMINT OIL

object_name: irritable bowel syndrome


subject: CHEBI:8364

subject_name: Prazosin

object_name: Presenile dementia


subject: CHEBI:8364

object_name: dementia


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: HIV wasting syndrome


subject: UNII:NQX9KB6PCL

object_name: HIV infection


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone


subject: UMLS:C0384570


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: UMLS:C2825029


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: Haemodialysis fistula thrombosis


subject: CHEBI:37941

object_name: kidney failure


subject: UMLS:C2826380

subject_name: Irinotecan-Eluting Beads

object_name: colorectal adenocarcinoma


subject: UMLS:C2826380

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:77319

subject_name: Oltipraz

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:8988

object_name: rectal carcinoma


subject: CHEBI:8988

object_name: rectal cancer


subject: CHEBI:8988

object_name: Childhood Rectal Carcinoma


subject: CHEBI:8988

object_name: colon carcinoma


subject: CHEBI:8988

object_name: colon cancer


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:229221

subject_name: Fruquintinib


subject: CHEBI:229221


subject: CHEBI:229221


subject: CHEBI:229221


subject: CHEBI:229221


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:4026

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:4026

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:4026

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:4026

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)